The objective of this study was to identify epigenetic miRNA associations with therapy-induced skin rash in patients receiving an EGFR targeting tumor treatment, since skin toxicity of EGFRI treatment has been shown to be a prognostic and therapy-predictive factor. This evidence concerns the gene EGFR and exanthem.